News

Venaxis Announces Termination of Proposed Transactions with Strand Life Sciences

Venaxis┬«, Inc. announced today that Venaxis, Strand Life Sciences Private Limited (Strand LS) and its U.S. subsidiary Strand Genomics Inc. (SGI), have agreed to terminate the previously announced transactions between the companies.  Read more…


Venaxis Announces Transaction with Strand Life Sciences

Venaxis┬«, Inc. (Nasdaq: APPY), announced today that it has entered into a series of agreements for a transaction with Strand Life Sciences Private Limited (Strand LS) and its shareholders.  Read more…


Venaxis Business Update

Venaxis┬«, Inc. announced that the Company will host an investor conference call to provide an update on regulatory and business matters, on Wednesday, June 24, 2015, at 4:30 p.m. ET. The conference call will be hosted by Steve Lundy, President and CEO.  Read more…